Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth

References

1. Bravo R., Frank R., Blundell P. A., Macdonald-Bravo H. 1987; Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326:515–517
   [Google Scholar]
2. Chamberlain R. W., Adams N., Saeed A. A., Simmonds P., Elliott R. M. 1997; Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. Journal of General Virology 78:1341–1347
   [Google Scholar]
3. Chang J., Yang S. -H., Cho Y. G., Hwang S. B., Hahn Y. S., Sung Y. C. 1998; Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with H-ras oncogene. Journal of Virology 72:3060–3065
   [Google Scholar]
4. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry 162:156–159
   [Google Scholar]
5. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
   [Google Scholar]
6. Clarke B. 1997; Molecular virology of hepatitis C virus. Journal of General Virology 78:2397–2410
   [Google Scholar]
7. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. 1993; WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825
   [Google Scholar]
8. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. 1995; Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96:224–230
   [Google Scholar]
9. Gale M. J., Korth M. J. Jr, Tang N. M., Tan S. -L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. 1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217–227
   [Google Scholar]
10. Gale M., Blakely C. M. Jr, Kwieciszewski B., Tan S. -L., Dossett M., Tang N. M., Korth M. J., Polyak S. J., Gretch D. R., Katze M. G. 1998; Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Molecular and Cellular Biology 18:5208–5218
    [Google Scholar]
11. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. 1993; The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816
    [Google Scholar]
12. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. 1991; Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428
    [Google Scholar]
13. Kaneko T., Tanji Y., Satoh S., Hijikata M., Asabe S., Kimura K., Shimotohno K. 1994; Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochemical and Biophysical Research Communications 205:320–326
    [Google Scholar]
14. Kato N., Lan K. H., Ono-Nita S. K., Shiratori Y., Omata M. 1997; Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. Journal of Virology 71:8856–8859
    [Google Scholar]
15. Kitabayashi I., Kawakami Z., Chiu R., Ozawa K., Matsuoka T., Toyoshima S., Umesono K., Evans R. M., Gachelin G., Yokoyama K. 1992; Transcriptional regulation of the c-jun gene by retinoic acid and E1A during differentiation of F9 cells. EMBO Journal 11:167–175
    [Google Scholar]
16. Koromilas A. E., Roy S., Barber G. N., Katze M. G., Sonenberg N. 1992; Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685–1689
    [Google Scholar]
17. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibshoosh H., Wigler M. H., Parsons R. 1997; PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947
    [Google Scholar]
18. Liu Y., Martindale J. L., Gorospe M., Holbrook N. J. 1996; Regulation of p21^WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Research 56:31–35
    [Google Scholar]
19. Michieli P., Chedid M., Lin D., Pierce J. H., Mercer W. E., Givol D. 1994; Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Research 54:3391–3395
    [Google Scholar]
20. Morgan D. O. 1995; Principles of CDK regulation. Nature 374:131–134
    [Google Scholar]
21. Morris G. F., Mathews M. B. 1990; Analysis ofthe proliferating cell nuclear antigen promoter and its response to adenovirus early region 1. Journal of Biological Chemistry 265:16116–16125
    [Google Scholar]
22. Ray R. B. 1995; Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth & Differentiation 6:1089–1096
    [Google Scholar]
23. Ray R., Miller D. M. 1991; Cloning and characterization of a human c-myc promoter-binding protein. Molecular and Cellular Biology 11:2154–2161
    [Google Scholar]
24. Ray R. B., Lagging L. M., Meyer K., Ray R. 1996; Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. Journal of Virology 70:4438–4443
    [Google Scholar]
25. Ray R. B., Steele R., Meyer K., Ray R. 1997; Transcriptional repression of p53 promoter by hepatitis C virus core protein. Journal of Biological Chemistry 272:10983–10986
    [Google Scholar]
26. Ray R. B., Steele R., Meyer K., Ray R. 1998; Hepatitis C virus core protein represses p21^{WAF1/Clp1/Sld1} promoter activity. Gene 208:331–336
    [Google Scholar]
27. Reed K. E., Xu J., Rice C. M. 1997; Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. Journal of Virology 71:7187–7197
    [Google Scholar]
28. Sakamuro D., Furukawa T., Takegami T. 1995; Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. Journal of Virology 69:3893–3896
    [Google Scholar]
29. Sheikh M. S., Rochefort H., Garcia M. 1995; Overexpression of p21^WAFI/CIpI induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11:1899–1905
    [Google Scholar]
30. Simmonds P. 1998; Variability of the hepatitis C virus genome. Current Studies in Hematology and Blood Transfusion 62:38–63
    [Google Scholar]
31. Stillman B. 1989; Initiation of eukaryotic DNA replication in vitro. Annual Review of Cell Biology 5:197–245
    [Google Scholar]
32. Tanimoto A., Ide Y., Arima N., Sasaguri Y., Padmanabhan R. 1997; The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochemical and Biophysical Research Communications 236:360–364
    [Google Scholar]
33. Tanji Y., Kaneko T., Satoh S., Shimotohno K. 1995; Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. Journal of Virology 69:3980–3986
    [Google Scholar]
34. Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., Beach D. 1993; p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704
    [Google Scholar]
35. Yang Z-Y., Perkins N. D., Ohno T., Nabel E. G., Nabel G. J. 1995; The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo . Nature Medicine 1:1052–1056
    [Google Scholar]
36. Zanotto P. M. de A., Gibbs M. J., Gould E. A., Holmes E. C. 1996; A reevaluation of the higher taxonomy of viruses based on RNA polymerases. Journal of Virology 70:6083–6096
    [Google Scholar]